Author

Mary Grace Bishop

Arkansas Children's Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Assay:imaging· 1 Approach:statistical model· 1

Frequent Co-Authors

Dakota M RedlingiD· 2 shared Kayleigh Amber RodrigueziD· 2 shared Kimberly StephensiD· 2 shared Laura R. OsborniD· 2 shared Ashley M Ezeldin· 1 shared Elizabeth A Duplechain· 1 shared Emma Zheng· 1 shared Renee FoxiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Dakota M RedlingORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Degraded myelin is associated with cold hypersensitivity in paclitaxel-induced peripheral neuropathy

Laura R Mora, Mary Grace Bishop, Kayleigh Amber Rodriguez, Dakota M Redling, Renee Fox, Ashley M Ezeldin, Emma Zheng, Kimberly Stephens

In paclitaxel-treated mice, cold hypersensitivity outlasts mechanical hypersensitivity and coincides with reduced myelin gene expression, lower chromatin accessibility at Egr2/Yy1 motifs, and fragmented sciatic nerve myelin.

bioRxiv · Oct 7, 2026 · PreprintNeuroscience✦ In-depth digest

A novel model of paclitaxel-induced peripheral neuropathy produces a clinically relevant phenotype in mice

Laura R. Osborn, Mary Grace Bishop, Kayleigh Amber Rodriguez, Dakota M Redling, Elizabeth A Duplechain, Kimberly Stephens

This study develops a novel mouse model of paclitaxel-induced peripheral neuropathy with persistent symptoms, mirroring clinical observations and offering a translational platform for therapeutic development.

Current Neuropharmacology · Apr 21, 2026Peer-reviewedNeuroscience